Market Overview

UPDATE: Wedbush Maintains Aéropostale at Overweight, Post Earnings

Related ARO
Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen
Aeropostale's Stock Plunges Following Bloomberg Report Company Is Preparing To Declare Bankruptcy

In a report published by Wedbush, analyst Betty Chen maintained his Outperform rating and $15.00 price target on Aéropostale (NYSE: ARO).

Wedbush reported that, “Q4 OpEPS of $0.24 (excl charges) vs. $0.44 LY beat our $0.21 & consensus' $0.22 on comps of (8)%. Sales declined (1.3) % to $797.7M with men's (4)% and women's (10)%. UPT rose +5%, AUR (7)%, and transactions (6)%. Gross margins declined (210) bp from (70) bp dip in merchandise margin and (140) bp of occupancy deleverage. Inventory (7)% psf. Cash is ~$3/share."

Shares of Aéropostale closed at $40.21 on Thursday.

Latest Ratings for ARO

Aug 2015Wolfe ResearchInitiates Coverage onPeer Perform
Jul 2015UBSDowngradesNeutralSell
May 2015Stephens & Co.MaintainsEqual-Weight

View More Analyst Ratings for ARO
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Reiteration Analyst Ratings


Related Articles (ARO)

View Comments and Join the Discussion!

Partner Center